{"id":"W2127462608","doi":"10.1053/j.seminoncol.2004.07.020","title":"Maximizing clinical benefit with trastuzumab","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Trastuzumab; Medicine; Vinorelbine; Oncology; Metastatic breast cancer; Internal medicine; Taxane; Capecitabine; Breast cancer; Chemotherapy; Gemcitabine; Clinical trial; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001990373,0.0005379512,0.004351234,0.000571885,0.00005128777,0.00001571997,0.0005125382,0.001587956,0.0004958661],"category_scores_gemma":[0.000520955,0.0004021673,0.0004942119,0.0008552499,0.000541638,0.00003498313,0.0002143186,0.003458067,0.0003100894],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.005213581,"about_ca_system_score_gemma":0.008918379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009520855,"about_ca_topic_score_gemma":0.0002547608,"domain_scores_codex":[0.9955531,0.0004099705,0.001523671,0.001012454,0.0005668863,0.000933881],"domain_scores_gemma":[0.9968833,0.001337839,0.0003976537,0.0008770732,0.0001185107,0.0003855613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001787559,0.0005113414,0.0003124308,0.01465387,0.0001708192,0.004632958,0.0001015556,0.000001827195,6.713731e-8,0.0001140451,0.001558728,0.9777636],"study_design_scores_gemma":[0.001834075,0.004645756,0.00004663287,0.08123073,0.0005934471,0.002926713,0.00007080985,0.000001629534,4.071354e-7,0.00009902097,0.9082304,0.0003203428],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006723323,0.9778532,0.00001319003,0.0003976658,0.0006044625,0.001917471,0.00002077353,0.00006288511,0.01906307],"genre_scores_gemma":[0.00001256762,0.9906633,0.005594985,0.0002215856,0.0006374515,0.0004522527,0.0000948467,0.0001588214,0.00216415],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9774433,"threshold_uncertainty_score":0.999843,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1762313080300225,"score_gpt":0.5363274342574647,"score_spread":0.3600961262274421,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}